GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sanara MedTech Inc (NAS:SMTI) » Definitions » E10

Sanara MedTech (Sanara MedTech) E10 : $-1.18 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Sanara MedTech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sanara MedTech's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.18 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 37.10% per year. During the past 5 years, the average E10 Growth Rate was 34.00% per year. During the past 10 years, the average E10 Growth Rate was 19.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sanara MedTech was 38.00% per year. The lowest was 2.90% per year. And the median was 7.85% per year.

As of today (2024-05-01), Sanara MedTech's current stock price is $31.84. Sanara MedTech's E10 for the quarter that ended in Dec. 2023 was $-1.18. Sanara MedTech's Shiller PE Ratio of today is .


Sanara MedTech E10 Historical Data

The historical data trend for Sanara MedTech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanara MedTech E10 Chart

Sanara MedTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.96 -4.74 -1.87 -1.74 -1.18

Sanara MedTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.74 -1.61 -1.65 -1.41 -1.18

Competitive Comparison of Sanara MedTech's E10

For the Medical Instruments & Supplies subindustry, Sanara MedTech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanara MedTech's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sanara MedTech's Shiller PE Ratio falls into.



Sanara MedTech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sanara MedTech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.03/129.4194*129.4194
=-0.030

Current CPI (Dec. 2023) = 129.4194.

Sanara MedTech Quarterly Data

per share eps CPI Adj_EPS
201403 -0.681 99.695 -0.884
201406 -0.952 100.560 -1.225
201409 -0.828 100.428 -1.067
201412 -0.327 99.070 -0.427
201503 -0.185 99.621 -0.240
201506 -0.608 100.684 -0.782
201509 -0.233 100.392 -0.300
201512 -0.481 99.792 -0.624
201603 0.016 100.470 0.021
201606 -0.910 101.688 -1.158
201609 0.098 101.861 0.125
201612 0.170 101.863 0.216
201703 0.019 102.862 0.024
201706 0.031 103.349 0.039
201709 -0.082 104.136 -0.102
201712 0.185 104.011 0.230
201803 -0.079 105.290 -0.097
201806 0.010 106.317 0.012
201809 -0.064 106.507 -0.078
201812 -0.221 105.998 -0.270
201903 -0.390 107.251 -0.471
201906 -0.150 108.070 -0.180
201909 -0.350 108.329 -0.418
201912 -0.410 108.420 -0.489
202003 -0.296 108.902 -0.352
202006 -0.181 108.767 -0.215
202009 -0.183 109.815 -0.216
202012 -0.039 109.897 -0.046
202103 -0.170 111.754 -0.197
202106 -0.160 114.631 -0.181
202109 -0.270 115.734 -0.302
202112 -0.480 117.630 -0.528
202203 -0.410 121.301 -0.437
202206 0.090 125.017 0.093
202209 -0.180 125.227 -0.186
202212 -0.510 125.222 -0.527
202303 -0.140 127.348 -0.142
202306 -0.220 128.729 -0.221
202309 -0.130 129.860 -0.130
202312 -0.030 129.419 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Sanara MedTech  (NAS:SMTI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sanara MedTech E10 Related Terms

Thank you for viewing the detailed overview of Sanara MedTech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanara MedTech (Sanara MedTech) Business Description

Traded in Other Exchanges
N/A
Address
1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.
Executives
Eric D Major director 751 MILLER DRIVE SE, LEESBURG VA 20175
Zachary B. Fleming officer: President - Surgical Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Shawn M. Bowman officer: President - Wound Care Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Rebecca E Mcmahon officer: President - R&D 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Sara N Ortwein director 5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298
Robert Andrew Desutter director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Eric D Tanzberger director 1929 ALLEN PARKWAY, HOUSTON TX 77219
Christopher A. Morrison officer: President - Telehealth Svcs. 1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102
Roszell Iii Mack director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Cgi Cellerate Rx, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Catalyst Rochal, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Bradley J. Gurasich 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
J Michael Carmena director, officer: Principal Executive Officer 1200 SUMMIT AVE STE 414, FORT WORTH TX 76102
Michael D. Mcneil officer: Chief Financial Officer 1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102
Catalyst Group, Inc. 10 percent owner 1375 ENCLAVE PARKWAY, HOUSTON TX 77077

Sanara MedTech (Sanara MedTech) Headlines